FindTrial
Sign In

Study to observe cancer directed treatment during COVID-19 pandemic situation.

Observational study of patients receiving cancer-directed systemic therapy during the COVID-19 pandemic

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/07/026533
Enrollment
10000
Registered
2020-07-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Not Applicable as observational study: Not Applicable as observational study Control Intervention1: Not Applicable as observational study: Not Applicable as observational study

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient with a diagnosis of malignancy (all types), or who are being worked up for a suspected diagnosis of malignancy. 2. Patient being evaluated in the Department of Medical Oncology and Pediatric Oncology. 3. All patients planned for or receiving systemic therapy in the OPD, ward, daycareand ICU will be eligible. 4. Patients who are on routine follow-up without active treatment will also be eligible.

Exclusion criteria

Exclusion criteria: NONE

Design outcomes

Primary

MeasureTime frame
To describe the patient demographics, treatment patterns and outcomes of patients planned for or receiving systemic cancer-directed therapy in the department of MedicalOncology and Pediatric Oncology at Tata Memorial Center, in various settings including the outpatient department (OPD), wards, daycare and ICU.Timepoint: 6 months—

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable—

Countries

India

Contacts

Public ContactDr Kumar Prabhash

TATA MEMORIAL CENTRE

kprabhash1@gmail.com02224177214

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 12, 2026